![Rajani Dinavahi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajani Dinavahi
Directeur Technique/Scientifique/R&D chez
ARDELYX, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Rajani Dinavahi is currently Chief Medical Officer at Ardelyx, Inc. since 2026.
Formerly, Dr. Dinavahi was Chief Medical Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2024 to 2025.
Education includes undergraduate and doctorate degrees from the University of Miami.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,08% | 01/04/2026 | 201 000 ( 0,08% ) | 1 M $ | 31/05/2026 |
Postes actifs de Rajani Dinavahi
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Directeur Technique/Scientifique/R&D | 01/04/2026 |
Anciens postes connus de Rajani Dinavahi
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2025 |
Formation de Rajani Dinavahi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
